Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts.
Aylin Ozsancak Ugurlu, Samy S Sidhom, Ali Khodabandeh...
https://pubmed.ncbi.nlm.nih.gov/24480997/Actively Recruiting
Led by Centre Hospitalier Régional d'Orléans · Updated on 2026-01-29
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying critically ill patients in the intensive care unit ICU who need emergency intubation due to acute respiratory failure. The study evaluates whether measuring end-tidal oxygen EtO2 on a facemask is a reliable way to monitor preoxygenation compared to measuring EtO2 in the pharynx using a nasopharyngeal catheter. This is important because hypoxemia is a common complication during intubation, and current practices rely on pulse oxygen saturation, which may not accurately reflect proper oxygenation. The study involves a prospective interventional design where both facemask EtO2 and pharyngeal EtO2 are monitored simultaneously during the intubation processfrom the start of preoxygenation until successful intubation. The procedure includes placing a nasopharyngeal catheter for pharyngeal oxygen measurement and using a facemask monitor as done in operating rooms. The total duration of the study procedure per patient will not exceed one hour, including device setup. Participants will undergo continuous oxygen monitoring during intubation, with researchers recording the percentage of expired oxygen at both measurement sites. They will also track the number of patients whose pulse oxygen saturation drops below 90%. This data will help determine the reliability of facemask EtO2 monitoring in ICU patients. The trial is sponsored by Centre Hospitalier Rgional dOrlans and includes adult patients requiring intubation with preoxygenation by noninvasive ventilation.
CONDITIONS
Feasibility of End-tidal Oxygen Concentration Monitoring During Preoxygenation for Intubation in the Intensive Care Unit.
M
Mai-Anh NAY, PH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Hospitalier Régional d'Orléans
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 hour
Participants undergo double monitoring of end-tidal oxygen concentration during the intubation procedure, including preoxygenation until successful intubation.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Aylin Ozsancak Ugurlu, Samy S Sidhom, Ali Khodabandeh...
https://pubmed.ncbi.nlm.nih.gov/24480997/Arnaud W Thille, Jean-Pierre Frat, Christian Brun-Buisson
https://pubmed.ncbi.nlm.nih.gov/24962719/Samir Jaber, Jibba Amraoui, Jean-Yves Lefrant...
https://pubmed.ncbi.nlm.nih.gov/16850003/Andres Carrillo, Gumersindo Gonzalez-Diaz, Miquel Ferrer...
https://pubmed.ncbi.nlm.nih.gov/22318634/Jean-Pierre Frat, Jean-Damien Ricard, Jean-Pierre Quenot...
https://pubmed.ncbi.nlm.nih.gov/30898520/Centre Hospitalier Régional d'Orléans
Lead Sponsor